Department of Clinical Sciences and Community Health, Universitá degli Studi di Milano, Milan, Italy.
Navarra Health Service, Pamplona, Navarra, Spain.
Ann Oncol. 2017 Sep 1;28(9):2286-2297. doi: 10.1093/annonc/mdx301.
From most recent available data, we predicted cancer mortality statistics in selected Latin American countries for the year 2017, with focus on lung cancer.
We obtained death certification data from the World Health Organization and population data from the Pan American Health Organization database for all neoplasms and selected cancer sites. We derived figures for Argentina, Brazil, Chile, Colombia, Cuba, Mexico and Venezuela. Using a logarithmic Poisson count data joinpoint model, we estimated number of deaths and age-standardized (world population) mortality rates in 2017.
Total cancer mortality rates are predicted to decline in all countries. The highest mortality rates for 2017 are in Cuba, i.e. 132.3/100 000 men and 93.3/100 000 women. Mexico had the lowest predicted rates, 64.7/100 000 men and 60.6/100 000 women. In contrast, the total number of cancer deaths is expected to rise due to population ageing and growth. Men showed declines in lung cancer trends in all countries and age groups considered, while only Colombian and Mexican women had downward trends. Stomach and (cervix) uteri rates are predicted to continue their declines, though mortality from these neoplasms remains comparatively high. Colorectal, breast and prostate cancer rates were predicted to decline moderately, as well as leukaemias. There was no clear pattern for pancreatic cancer. Between 1990 and 2017 about 420 000 cancer deaths were avoided in 5 of the 7 countries, no progress was observed in Brazil and Cuba.
Cancer mortality rates for 2017 in seven selected Latin American countries are predicted to decline, though there was appreciable variability across countries. Mortality from major cancers-including lung and prostate-and all cancers remains comparatively high in Cuba, indicating the need for improved prevention and management.
根据最新可用数据,我们预测了 2017 年选定的拉丁美洲国家的癌症死亡率统计数据,重点关注肺癌。
我们从世界卫生组织获得了所有肿瘤和选定癌症部位的死亡证明数据,并从泛美卫生组织数据库获得了人口数据。我们获得了阿根廷、巴西、智利、哥伦比亚、古巴、墨西哥和委内瑞拉的数据。使用对数泊松计数数据连接点模型,我们估计了 2017 年的死亡人数和年龄标准化(世界人口)死亡率。
预计所有国家的癌症总死亡率都会下降。2017 年死亡率最高的是古巴,即男性 132.3/100000,女性 93.3/100000。墨西哥的预测死亡率最低,男性为 64.7/100000,女性为 60.6/100000。相反,由于人口老龄化和增长,预计癌症死亡总数将会上升。在所有考虑的国家和年龄组中,男性的肺癌趋势都呈下降趋势,而只有哥伦比亚和墨西哥的女性呈下降趋势。预计胃癌和(子宫颈)癌症的死亡率将继续下降,尽管这些肿瘤的死亡率仍然相对较高。结直肠癌、乳腺癌和前列腺癌的死亡率预计将适度下降,白血病也是如此。胰腺癌没有明显的趋势。在 1990 年至 2017 年期间,7 个国家中的 5 个国家避免了约 42 万例癌症死亡,巴西和古巴没有取得进展。
预计 2017 年选定的 7 个拉丁美洲国家的癌症死亡率将会下降,但各国之间存在相当大的差异。包括肺癌和前列腺癌在内的主要癌症以及所有癌症的死亡率在古巴仍然相对较高,这表明需要改进预防和管理。